Cytogenetic effects in children treated with methylphenidate.

[1]  H. Norppa,et al.  Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective , 2004, Cytogenetic and Genome Research.

[2]  S. Z. Abdel‐Rahman,et al.  Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco‐specific nitrosamine NNK , 2004, Environmental and molecular mutagenesis.

[3]  V. O. Wagner,et al.  D-Methylphenidate is non-genotoxic in in vitro and in vivo assays. , 2003, Mutation research.

[4]  H. Hu,et al.  Genetic toxicity of methamphetamine in vitro and in human abusers , 2003, Environmental and molecular mutagenesis.

[5]  Michael Fenech,et al.  Biomarkers of genetic damage for cancer epidemiology. , 2002, Toxicology.

[6]  S. Z. Abdel‐Rahman,et al.  Human sensitivity to 1,3-butadiene: role of microsomal epoxide hydrolase polymorphisms. , 2001, Carcinogenesis.

[7]  S. Z. Abdel‐Rahman,et al.  The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. , 2000, Cancer letters.

[8]  J. Haseman,et al.  Decreased incidence of spontaneous mammary gland neoplasms in female F344 rats treated with amphetamine, methylphenidate, or codeine. , 1996, Cancer letters.

[9]  J. Dunnick,et al.  Experimental studies on the long-term effects of methylphenidate hydrochloride. , 1995, Toxicology.

[10]  Cathleen Clancy,et al.  Medical toxicology: Diagnosis and treatment of human poisoning , 1995 .

[11]  J. Swanson,et al.  More frequent diagnosis of attention deficit-hyperactivity disorder. , 1995, The New England journal of medicine.

[12]  M Fenech,et al.  The cytokinesis-block micronucleus technique and its application to genotoxicity studies in human populations. , 1993, Environmental health perspectives.

[13]  R. Tennant,et al.  Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays. , 1993, Environmental health perspectives.

[14]  G. Friedman,et al.  Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. , 1989, Cancer research.

[15]  D. Johnston,et al.  Sensitivity to genotoxic effects of bleomycin in humans: Possible relationship to environmental carcinogenesis , 1989, International journal of cancer.

[16]  C. Rudd,et al.  Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: intralaboratory results for sixty-three coded chemicals tested at SRI International. , 1988, Environmental and molecular mutagenesis.

[17]  E. Zeiger,et al.  Chromosome aberrations and sister chromatid exchanges in chinese hamster ovary cells: Evaluations of 108 chemicals , 1987, Environmental and molecular mutagenesis.

[18]  E. Zeiger,et al.  Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. , 1986, Environmental mutagenesis.

[19]  P. Price,et al.  Ritalin, Benzedrine and Dexedrine do not transform F 1706 rat cells. , 1978, Cancer letters.

[20]  S. Wolff,et al.  New Giemsa method for the differential staining of sister chromatids , 1974, Nature.